News | Latest Breaking News Stories & Headlines

AstraZeneca's $50 billion US investment as tarrifs loom

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy.

Business • 22 Jul

Merck shells out $10 billion for London-based Verona

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said today, strengthening the US drugmaker's respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer treatment.

Business • 09 Jul

US President Donald Trump said today he would cut prescription drug prices by 59%

Trump says he will cut drug prices by 59%

US President Donald Trump said he would cut prescription drug prices by 59%, but gave no further details about his plan to lower medicine costs ahead of a health-related event at the White House later today.

Business • 12 May

GSK said it had identified options within its supply chain and productivity initiatives to mitigate any hit from possible pharmaceutical tariffs

GSK 'well positioned' for tariffs after beating forecasts

Drugmaker GSK has today reaffirmed its outlook for 2025 and said it was "well positioned" to mitigate any hit from potential sector-specific tariffs, after first quarter results beat expectations.

Business • 30 Apr

Pfizer had an Irish workforce of about 5,000 across four locations based in Cork, Dublin and Kildare

Pfizer misses first quarter revenue expectations

Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and reported lower first-quarter revenue due to declining sales of its Paxlovid Covid-19 treatment.

Business • 29 Apr

Merck is estimating $200m in additional costs for tariffs

Merck posts higher profit, puts tariffs cost at $200m

Merck said today its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a January decision to pause shipments of its Gardasil vaccine to China due to a downturn in demand.

Business • 24 Apr

A number of pharmaceutical companies sent a letter to the EU Commission President warning that the EU could lose €100bn in new investment

Pharma companies worried about threat of tariffs - IPHA

Pharmaceutical companies are worried about the threat of tariffs and what they would mean for investment in Europe, the Chief Executive of the Irish Pharmaceutical Healthcare Association has said.

Business • 17 Apr

Novartis said it plans to build six new manufacturing plants in the US

Novartis plans to invest $23 billion in US sites

Swiss drugmaker Novartis said today it plans to spend $23 billion to build and expand 10 facilities in the US, as it grapples with renewed threats of drug import duties from the Trump administration.

Business • 11 Apr

Donald Trump has long railed against what he calls the unfair treatment of US automotive exports in foreign markets.

Trump says to introduce 25% tariffs on cars, pharma

US President Donald Trump has said he intends to impose auto tariffs "in the neighbourhood of 25%" and similar duties on semiconductors and pharmaceutical imports, the latest in a series of measures threatening to upend international trade.

Business • 19 Feb

Most investors in the financial services sector are intent on establishing or expanding operations in Ireland over the next year, according to the survey

79% of FDI decision-makers planning Irish investment

Nearly 80% of foreign direct investment decision-makers are planning to establish or expand operations in Ireland over the next year.

Business • 30 Jul 24

AstraZeneca said the acquisition would help to boost its rare disease division, Alexion

AstraZeneca to acquire Amolyt Pharma for $1bn

AstraZeneca is to acquire Amolyt Pharma in a deal potentially worth more than $1 billion.

Business • 14 Mar 24

Merck said its sales in the second quarter stood at $15 billion, up from $14.6 billion a year ago

Merck beats quarterly sales estimate

Merck & Co has today posted better-than-expected second-quarter sales on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.

Business • 01 Aug 23

Chanelle Pharmaceutical, founded by Michael Burke, saw revenues rise by 24% last year

Chanelle Pharma sees profits rise 35.5% to €17.2m

Pre-tax profits at Chanelle Pharmaceuticals increased by 35.5% last year to €17.19m.

Business • 15 Feb 23

Novartis does not have vaccines in the works for Covid-19

Novartis Q4 sales, core net income trail expectations

Switzerland's Novartis said delays of two blockbuster hopefuls - heart drug Leqvio that cost it $10 billion and $2.1m-per-patient Zolgensma - remain in regulators' hands, dragging on sales already hit by the pandemic.

Business • 26 Jan 21

Drug companies are owed money by both Greek hospitals and the state-run health insurer EOPYY

Greece owes pharma companies €1.1 billion

Greece has racked up mounting debts with international drugmakers and now owes the industry more than €1.1 billion, a leading industry official has said.

Business • 28 May 15

In 2014 the IPHA wrote to the Department of Health to outline concerns about Government moves to reduce medicine prices

IPHA claims 500 jobs lost due to drug-pricing

The pharmaceutical industry claims that 500 jobs have been lost as a result of the Government's drug-pricing policies.

News • 30 Mar 15

Actavis offer values Allergan at $219 per share

Allergan agrees to Actavis deal for $66 billion

Allergan has agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals.

Business • 17 Nov 14

Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals for $5.6bn

Mallinckrodt to buy Questcor Pharma for $5.6bn

Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $5.6bn cash-and-stock deal expected to expand the firm's drive in the speciality drugs field, the companies have announced.

Business • 07 Apr 14

Pharmaceuticals